Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

It’s a type of drug called a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide ... highlights the basics of Mounjaro’s dosage. The strengths in this chart are ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Amgen CEO Robert Bradway said the company's obesity drug could find its space in the market due to once-monthly dosing and ...

Background/Aims Studies in animals suggest a physiological role for glucagon-like peptide-1-(7–36)-amide (GLP-1 ... Results Graded GLP-1 infusions resulted in a dose dependent reduction in food intake ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.